CNSY · NASDAQ · Medical - Pharmaceuticals

Cerenome (CNSY)

Diagnostic testing and targeted radiotherapy development for central nervous system cancers.

$2.08
vs last close+0.18 (+9.48%)

No ownership filings on record for this listing.